16 05, 2023 Daniela Massi et al., Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group. adlitterio663392023-10-17T09:13:02+02:00 Read More
12 05, 2023 Francesca Bersani et al., Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity adlitterio663392023-10-17T09:12:09+02:00 Read More
11 05, 2023 Giulia Simoncini et al., NRAS-mutated oncocytic benign liver lesion in an organ donor: Pitfalls and troubles in frozen section diagnosis and risk assessment adlitterio663392023-05-11T16:29:32+02:00 Read More
4 05, 2023 Büsra Saruhan., Gastrik kanser hastalar?nda mikrosatellite instabilite durumunun retrospektif de?erlendirilmesi:tek merkez deneyimi adlitterio663392023-05-04T14:45:49+02:00 Read More
4 05, 2023 Federica Zito Marino et al., NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS. adlitterio663392023-10-17T09:08:15+02:00 Read More
1 05, 2023 Elena Orlandi et al., Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment adlitterio663392023-10-17T09:07:01+02:00 Read More
26 04, 2023 Diatech Pharmacogenetics announces Investment from TA to Fuel Strategic Growth Initiatives Diatech Pharmacogenetics announces Investment from TA to Fuel Strategic Growth Initiatives News Diatech Pharmacogenetics announces Investment from TA to Fuel Strategic Growth Initiatives adlitterio663392023-04-26T11:58:30+02:00 Read More
21 04, 2023 Diatech Pharmacogenetics will join the Precision Med Exhibition of Dubai on May 23-24/2023 Diatech Pharmacogenetics will join the Precision Med Exhibition of Dubai on May 23-24/2023 Events, News Diatech Pharmacogenetics will join the Precision Med Exhibition of Dubai on May 23-24/2023 adlitterio663392023-04-21T17:28:01+02:00 Read More
13 04, 2023 Valentina Angerilli et al., HER2-low in gastro-oesophageal adenocarcinoma: a real-world pathological perspective adlitterio663392023-04-13T16:24:59+02:00 Read More
1 04, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – February and March 2023 adlitterio663392023-06-28T10:51:22+02:00 Read More
